Drotrecogin alfa: excess mortality in the least severely ill patients.
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D011486:Protein C / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000009:adverse effects* / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy / Q000401:mortality*
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins